Dulacil ™ 250
Dulacil™ 250 is an oral antifungal formulation developed to assist healthcare professionals in the management of fungal infections affecting skin, hair, and nails. The formulation supports systemic antifungal therapy in dermatological conditions where topical management alone may be insufficient.
It is formulated to support fungal infection control while helping maintain overall skin and nail health under medical supervision.
Dosage Form
Tablets
• Therapeutic Category
Antifungal
• Strength
250 mg
• Pack Size
10 × 7 Blister
• Route of Administration
Oral
• Formulated For
Systemic antifungal therapy under physician supervision
Dulacil™ 250 contains Terbinafine Hydrochloride, an allylamine antifungal agent that works by inhibiting squalene epoxidase, an essential enzyme involved in fungal cell membrane synthesis.
This mechanism assists in reducing fungal proliferation by disrupting ergosterol production required for fungal cell integrity. The formulation supports management of dermatophyte infections commonly encountered in clinical dermatology practice.
Oral administration allows systemic distribution, assisting in the management of infections involving deeper skin layers, scalp, or nail structures as clinically indicated.